Chardan Capital Markets Llc - Jun 21, 2024 Form 3 Insider Report for ANEW Medical, Inc. (WENA)

Role
10%+ Owner
Signature
Chardan Capital Markets LLC, By: /s/ Steven Urbach, Manager
Stock symbol
WENA
Transactions as of
Jun 21, 2024
Transactions value $
$0
Form type
3
Date filed
7/1/2024, 06:14 PM
Previous filing
Nov 13, 2024
Next filing
Jul 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding WENA Common Stock 1.63M Jun 21, 2024 Direct F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding WENA Warrant Jun 21, 2024 Common Stock 115K $11.50 Direct F4
holding WENA Unit Purchase Options (Option to Buy) Jun 21, 2024 Common Stock, Warrant and Right 725K $11.50 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents (i) 1,500,000 shares of the Issuer's common stock (the "Common Stock") assigned to Chardan Capital Markets LLC ("CCM") by Dr. Joseph Sinkule, the Issuer's Chief Executive Officer, as partial payment of an investment banking fee due to CCM in connection with the Issuer's initial business combination, which was consummated on June 21, 2024, (ii) 115,000 shares of Common Stock issued to CCM upon conversion of the Private Units and (iii) 11,500 shares of Common Stock issued to CCM upon conversion of the rights included in the Private Units. The Issuer issued 115,000 private units (the "Private Units") to CCM in a private placement that closed concurrently with the Issuer's initial public offering on April 4, 2022 (including exercise of the underwriter's over-allotment option).
F2 Each Private Unit consists of one share of Common Stock, one redeemable warrant to purchase one share of Common Stock at an exercise price of $11.50 per share and one right entitling the holder to receive one-tenth (1/10) of a share of Common Stock upon consummation of the Issuer's initial business combination.
F3 This Form 3 is being filed by CCM. Chardan Securities LLC ("Chardan Securities") is the sole Class A Member and 99% owner of CCM and as such has voting and investment discretion with respect to the Common Stock held of record by CCM and may be deemed to have beneficial ownership of the Common Stock held directly by CCM. Each of Jonas Grossman, Steven Urbach and Kerry Propper is a member of Chardan Securities, and as such has voting and investment discretion with respect to the Common Stock held of record by CCM and may be deemed to have beneficial ownership of the Common Stock held directly by CCM. Each of Mr. Grossman, Mr. Urbach and Mr. Propper disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly.
F4 Represents 115,000 shares of Common Stock issuable upon exercise of the warrant included in the Private Units. Each warrant entitles the holder thereof to purchase one share of Common Stock at an exercise price $11.50 per share. Each warrant became exercisable upon the completion of the Issuer's initial business combination, and will expire on the five year anniversary of the closing date of the Issuer's initial business combination or earlier upon redemption or liquidation.
F5 Represents (i) 345,000 shares of Common Stock included in the unit issuable upon exercise of the unit purchase option, (ii) 345,000 shares of Common Stock issuable upon exercise of the warrant included in the unit issuable upon exercise of the unit purchase option and (iii) 34,500 shares of Common Stock underlying the right included in the unit issuable upon the exercise of the unit purchase option. The units issuable upon exercise of the unit purchase option are identical to the Private Units. The Issuer sold to CCM, for $100, an option to purchase up to 345,000 units (the "Unit Purchase Option") exercisable at $11.50 per unit concurrently with the closing of the Issuer's initial public offering on April 4, 2022 (including exercise of the underwriter's over-allotment option).